{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:33:51Z","timestamp":1792118031122,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2006,10,28]],"date-time":"2006-10-28T00:00:00Z","timestamp":1161993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2006,12,4]]},"DOI":"10.1007\/s00403-006-0711-z","type":"journal-article","created":{"date-parts":[[2006,10,27]],"date-time":"2006-10-27T12:40:31Z","timestamp":1161952831000},"page":"381-388","source":"Crossref","is-referenced-by-count":17,"title":["Immunohistochemical study on topoisomerase II\u03b1, Ki-67 and cytokeratin-19 in oral lichen planus lesions"],"prefix":"10.1007","volume":"298","author":[{"given":"Riikka","family":"Mattila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalle","family":"Alanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stina","family":"Syrj\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,10,28]]},"reference":[{"key":"711_CR1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0006-291X(03)01169-0","volume":"307","author":"N Akimitsu","year":"2003","unstructured":"Akimitsu N, Kamura K, Tone S, Sakaguchi A, Kikuchi A, Hamamoto H, Sekimizu K (2003) Induction of apoptosis by depletion of DNA topoisomerase IIalpha in mammalian cells. Biochem Biophys Res Commun 307:301\u2013307","journal-title":"Biochem Biophys Res Commun"},{"key":"711_CR2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/379225a0","volume":"379","author":"JM Berger","year":"1996","unstructured":"Berger JM, Gamblin SJ, Harrison SC, Wang JC (1996) Structure and mechanism of DNA topoisomerase II. Nature 379:225\u2013232","journal-title":"Nature"},{"key":"711_CR3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1079-2104(99)70116-2","volume":"88","author":"BK Bloor","year":"1999","unstructured":"Bloor BK, Malik FK, Odell EW, Morgan PR (1999) Quantitative assessment of apoptosis in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88:187\u2013195","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"711_CR4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2559.1990.tb00788.x","volume":"17","author":"DC Brown","year":"1990","unstructured":"Brown DC, Gatter KC (1990) Monoclonal antibody Ki-67: its use in histopathology. Histopathology 17:489\u2013503","journal-title":"Histopathology"},{"key":"711_CR5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2184.1992.tb01435.x","volume":"25","author":"S Bruno","year":"1992","unstructured":"Bruno S, Darzynkiewicz Z (1992) Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells. Cell Prolif 25:31\u201340","journal-title":"Cell Prolif"},{"key":"711_CR6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/gyno.2002.6747","volume":"86","author":"H Brustmann","year":"2002","unstructured":"Brustmann H, Naude S (2002) Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions. Gynecol Oncol 86:192\u2013199","journal-title":"Gynecol Oncol"},{"key":"711_CR7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/000348940611500102","volume":"115","author":"L Davies","year":"2006","unstructured":"Davies L, Hardin NJ, Beatty BG (2006) Can Ki-67 predict recurrence of NO squamous cell carcinoma of the tongue? Ann Otol Rhinol Laryngol 115:12\u201317","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"711_CR8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2184.2003.00282.x","volume":"36","author":"U Dissanayake","year":"2003","unstructured":"Dissanayake U, Johnson NW, Warnakulasuriya KA (2003) Comparison of cell proliferation in the centre and advancing fronts of oral squamous cell carcinomas using Ki-67 index. Cell Prolif 36:255\u2013264","journal-title":"Cell Prolif"},{"key":"711_CR9","first-page":"409","volume":"10","author":"D Gibbons","year":"1997","unstructured":"Gibbons D, Fogt F, Kasznica J, Holden J, Nikulasson S (1997) Comparison of topoisomerase II alpha and MIB-1 expression in uterine cervical squamous lesions. Mod Pathol 10:409\u2013413","journal-title":"Mod Pathol"},{"key":"711_CR10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0266-4356(98)90708-2","volume":"36","author":"SC Girod","year":"1998","unstructured":"Girod SC, Pfeiffer P, Ries J, Pape HD (1998) Proliferative activity and loss of function of tumour suppressor genes as \u2018biomarkers\u2019 in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma. Br J Oral Maxillofac Surg 36:252\u2013260","journal-title":"Br J Oral Maxillofac Surg"},{"key":"711_CR11","first-page":"159","volume":"93","author":"MA Gonzalez-Moles","year":"1996","unstructured":"Gonzalez-Moles MA, Caballero R, Rodriguez-Archilla A, Ruiz-Avila I, Bravo I (1996) Prognosis value of the expression of Ki-67 for squamous cell carcinoma of the oral cavity. Acta Stomatol Belg 93:159\u2013165","journal-title":"Acta Stomatol Belg"},{"key":"711_CR12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.humpath.2004.02.004","volume":"35","author":"H Hafian","year":"2004","unstructured":"Hafian H, Venteo L, Sukhanova A, Nabiev I, Lefevre B, Pluot M (2004) Immunohistochemical study of DNA topoisomerase I, DNA topoisomerase II alpha, p53, and Ki-67 in oral preneoplastic lesions and oral squamous cell carcinomas. Hum Pathol 35:745\u2013751","journal-title":"Hum Pathol"},{"key":"711_CR13","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1083\/jcb.103.6.2569","volume":"103","author":"MM Heck","year":"1986","unstructured":"Heck MM, Earnshaw WC (1986) Topoisomerase II: a specific marker for cell proliferation. J Cell Biol 103:2569\u20132581","journal-title":"J Cell Biol"},{"key":"711_CR14","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1073\/pnas.85.4.1086","volume":"85","author":"MM Heck","year":"1988","unstructured":"Heck MM, Hittelman WN, Earnshaw WC (1988) Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proc Natl Acad Sci USA 85:1086\u20131090","journal-title":"Proc Natl Acad Sci USA"},{"key":"711_CR15","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2559.2006.02402.x","volume":"48","author":"P Jalava","year":"2006","unstructured":"Jalava P, Kuopio T, Juntti-Patinen L, Kotkansalo T, Kronqvist P, Collan Y (2006) Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index. Histopathology 48:674\u2013682","journal-title":"Histopathology"},{"key":"711_CR16","first-page":"89","volume":"134","author":"K Lindberg","year":"1989","unstructured":"Lindberg K, Rheinwald JG (1989) Suprabasal 40\u00a0kd keratin (K19) expression as an immunohistologic marker of premalignancy in oral epithelium. Am J Pathol 134:89\u201398","journal-title":"Am J Pathol"},{"key":"711_CR17","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0046-8177(97)90256-2","volume":"28","author":"BJ Lynch","year":"1997","unstructured":"Lynch BJ, Guinee DG, Jr. Holden JA (1997) Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer. Hum Pathol 28:1180\u20131188","journal-title":"Hum Pathol"},{"key":"711_CR18","first-page":"278","volume":"26","author":"R Mattila","year":"2004","unstructured":"Mattila R, Alanen K, Syrjanen S (2004) DNA content as a prognostic marker of oral lichen planus with a risk of cancer development. Anal Quant Cytol Histol 26:278\u2013284","journal-title":"Anal Quant Cytol Histol"},{"key":"711_CR19","first-page":"4519","volume":"58","author":"JP McPherson","year":"1998","unstructured":"McPherson JP, Goldenberg GJ (1998) Induction of apoptosis by deregulated expression of DNA topoisomerase IIalpha. Cancer Res 58:4519\u20134524","journal-title":"Cancer Res"},{"key":"711_CR20","first-page":"229","volume":"23","author":"T Mirtti","year":"2001","unstructured":"Mirtti T, Kallajoki M, Aaltonen M, Alanen K (2001) Cyclin A and Ki-67 with DNA content in benign and malignant prostatic epithelial lesions. Anal Quant Cytol Histol 23:229\u2013237","journal-title":"Anal Quant Cytol Histol"},{"key":"711_CR21","first-page":"205","volume":"31","author":"R Moll","year":"1998","unstructured":"Moll R (1998) Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors. Subcell Biochem 31:205\u2013262","journal-title":"Subcell Biochem"},{"key":"711_CR22","first-page":"187","volume":"37","author":"M Nie","year":"2002","unstructured":"Nie M, Zhong L, Zeng G, Li B (2002) The changes of cytokeratin 19 during oral carcinogenesis. Zhonghua Kou Qiang Yi Xue Za Zhi 37:187\u2013190","journal-title":"Zhonghua Kou Qiang Yi Xue Za Zhi"},{"key":"711_CR23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0901-5027(00)80122-8","volume":"29","author":"H Raybaud","year":"2000","unstructured":"Raybaud H, Fortin A, Bairati I, Morency R, Monteil RA, Tetu B (2000) Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma. Int J Oral Maxillofac Surg 29:36\u201341","journal-title":"Int J Oral Maxillofac Surg"},{"key":"711_CR24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2273.1994.tb01140.x","volume":"19","author":"NJ Roland","year":"1994","unstructured":"Roland NJ, Caslin AW, Bowie GL, Jones AS (1994) Has the cellular proliferation marker Ki67 any clinical relevance in squamous cell carcinoma of the head and neck? Clin Otolaryngol 19:13\u201318","journal-title":"Clin Otolaryngol"},{"key":"711_CR25","first-page":"1511","volume":"14","author":"M Ruutu","year":"2005","unstructured":"Ruutu M, Johansson B, Grenman R, Syrjanen S (2005) Two different global gene expression profiles in cancer cell lines established from etiologically different oral carcinomas. Oncol Rep 14:1511\u20131517","journal-title":"Oncol Rep"},{"key":"711_CR26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","volume":"182","author":"T Scholzen","year":"2000","unstructured":"Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182:311\u2013322","journal-title":"J Cell Physiol"},{"key":"711_CR27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/10454411980090010501","volume":"9","author":"C Scully","year":"1998","unstructured":"Scully C, Beyli M, Ferreiro MC, Ficarra G, Gill Y, Griffiths M, Holmstrup P, Mutlu S, Porter S, Wray D (1998) Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 9:86\u2013122","journal-title":"Crit Rev Oral Biol Med"},{"key":"711_CR28","first-page":"177","volume":"20","author":"GP Stathopoulos","year":"2000","unstructured":"Stathopoulos GP, Kapranos N, Manolopoulos L, Papadimitriou C, Adamopoulos G (2000) Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck. Anticancer Res 20:177\u2013182","journal-title":"Anticancer Res"},{"issue":"Suppl 1","key":"711_CR29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2184.35.s1.11.x","volume":"35","author":"Y Taniguchi","year":"2002","unstructured":"Taniguchi Y, Nagao T, Maeda H, Kameyama Y, Warnakulasuriya KA (2002) Epithelial cell proliferation in oral lichen planus. Cell Prolif 35 Suppl 1:103\u2013109","journal-title":"Cell Prolif"},{"key":"711_CR30","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s004050050202","volume":"256","author":"LA Velden van der","year":"1999","unstructured":"van der Velden LA, Manni JJ, Ramaekers FC, Kuijpers W (1999) Expression of intermediate filament proteins in benign lesions of the oral mucosa. Eur Arch Otorhinolaryngol 256:514\u2013519","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"711_CR31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-3-642-80169-3_5","volume":"90","author":"KA Warnakulasuriya","year":"1996","unstructured":"Warnakulasuriya KA, Johnson NW (1996) Importance of proliferation markers in oral pathology. Curr Top Pathol 90:147\u2013177","journal-title":"Curr Top Pathol"},{"key":"711_CR32","doi-asserted-by":"crossref","unstructured":"WHO World Health Organization Collaborating Centre for Oral Precancerous Lesions (1978) Definition of leukoplakia and related lesions; an aid to study precancer. Oral Surg Oral Med Oral Pathol 46:518\u2013539","DOI":"10.1016\/0030-4220(78)90383-3"},{"key":"711_CR33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/(SICI)1097-0045(20000301)42:4<280::AID-PROS5>3.0.CO;2-P","volume":"42","author":"JH Willman","year":"2000","unstructured":"Willman JH, Holden JA (2000) Immunohistochemical staining for DNA topoisomerase II-alpha in benign, premalignant, and malignant lesions of the prostate. Prostate 42:280\u2013286","journal-title":"Prostate"},{"key":"711_CR34","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1128\/MCB.26.9.3414-3431.2006","volume":"26","author":"K Yoshida","year":"2006","unstructured":"Yoshida K, Yamaguchi T, Shinagawa H, Taira N, Nakayama KI, Miki Y (2006) Protein kinase C delta activates topoisomerase IIalpha to induce apoptotic cell death in response to DNA damage. Mol Cell Biol 26:3414\u20133431","journal-title":"Mol Cell Biol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-006-0711-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-006-0711-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-006-0711-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:37:36Z","timestamp":1559065056000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-006-0711-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,28]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,12,4]]}},"alternative-id":["711"],"URL":"https:\/\/doi.org\/10.1007\/s00403-006-0711-z","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,28]]}}}